These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16334910)

  • 1. Metronomic chemoimmunotherapy in a patient with refractory Waldenstrom's macroglobulinemia.
    Fassas AB; Kiwan E; Roberts J; Burr T; Tricot G; Anaissie E; Barlogie B
    Leuk Lymphoma; 2005 Nov; 46(11):1675-7. PubMed ID: 16334910
    [No Abstract]   [Full Text] [Related]  

  • 2. CD52 expression in Waldenstrom's macroglobulinemia: implications for alemtuzumab therapy and response assessment.
    Owen RG; Hillmen P; Rawstron AC
    Clin Lymphoma; 2005 Mar; 5(4):278-81. PubMed ID: 15794865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future therapeutic approach for Waldenström's macroglobulinemia.
    Souchet-Cömpain L; Choquet S; Leblond V; Nguyen S
    Immunotherapy; 2014; 6(3):333-48. PubMed ID: 24762077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel agents in the treatment of Waldenström's macroglobulinemia.
    Treon SP; Hatjiharissi E; Leleu X; Moreau AS; Roccaro A; Hunter ZR; Soumerai JD; Ciccarelli B; Xu L; Sacco A; Ngo HT; Jia X; Yang C; Adamia S; Branagan AR; Ho AW; Santos DD; Tournilhac O; Manning RJ; Leduc R; O'Connor K; Nelson M; Patterson CJ; Ghobrial I
    Clin Lymphoma Myeloma; 2007 Aug; 7 Suppl 5():S199-206. PubMed ID: 17877845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia.
    Gavriatopoulou M; Kastritis E; Kyrtsonis MC; Vassilakopoulos TP; Roussou M; Fotiou D; Migkou M; Mpakiri M; Tasidou A; Terpos E; Dimopoulos MA
    Leuk Lymphoma; 2017 Jun; 58(6):1506-1508. PubMed ID: 27724158
    [No Abstract]   [Full Text] [Related]  

  • 6. Waldenström's macroglobulinaemia: laboratory diagnosis and treatment.
    Owen RG; Johnson SA; Morgan GJ
    Hematol Oncol; 2000 Jun; 18(2):41-9. PubMed ID: 10960874
    [No Abstract]   [Full Text] [Related]  

  • 7. The Management of Relapsed or Refractory Waldenström's Macroglobulinemia.
    García-Sanz R; Tedeschi A
    Hematol Oncol Clin North Am; 2023 Aug; 37(4):727-749. PubMed ID: 37246089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's Macroglobulinemia and mast cell disorders.
    Santos DD; Hatjiharissi E; Tournilhac O; Chemaly MZ; Leleu X; Xu L; Patterson C; Branagan AR; Manning RJ; Ho AW; Hunter ZR; Dimmock EA; Kutok JL; Churchill WH; Castells MC; Tai YT; Anderson KC; Treon SP
    Clin Lymphoma Myeloma; 2006 May; 6(6):478-83. PubMed ID: 16796779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab-based treatments in Waldenström's macroglobulinemia.
    Dimopoulos MA; Kastritis E; Roussou M; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Tassidou A; Terpos E
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):59-61. PubMed ID: 19362975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-interferon therapy in advanced unresponsive immunoblastic lymphoma evolved from Waldenström's macroglobulinemia.
    Carella AM
    Haematologica; 1990; 75(6):581. PubMed ID: 1711503
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.
    Shaikh A; Habermann TM; Fidler ME; Kumar S; Leung N
    Clin Exp Nephrol; 2008 Aug; 12(4):292-295. PubMed ID: 18288560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy.
    Yi JH; Kim SJ; Ko YH; Kim WS
    Leuk Lymphoma; 2011 Feb; 52(2):317-20. PubMed ID: 21067447
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome.
    Varettoni M; Marchioni E; Bonfichi M; Picchiecchio A; Arcaini L; Arbasino C; Gotti M; Da Vià M; Delmonte M; Sciarra R; Cazzola M
    Am J Hematol; 2015 Aug; 90(8):E152-3. PubMed ID: 25975811
    [No Abstract]   [Full Text] [Related]  

  • 14. Fludarabine, cyclophosphamide, and rituximab in salvage therapy of Waldenström's macroglobulinemia.
    Tedeschi A; Ricci F; Goldaniga MC; Benevolo G; Varettoni M; Motta M; Pioltelli P; Gini G; Barate' C; Luraschi A; Vismara E; Frustaci AM; Nichelatti M; Vitolo U; Baldini L; Morra E
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):231-4. PubMed ID: 23490992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bendamustine therapy in patients with relapsed or refractory Waldenström's macroglobulinemia.
    Treon SP; Hanzis C; Tripsas C; Ioakimidis L; Patterson CJ; Manning RJ; Sheehy P
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):133-5. PubMed ID: 21454214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effective treatment with rituximab in two patients with Waldenström macroglobulinemia].
    Yoshimi A; Arai S; Iijima K; Iki S; Usuki K; Urabe A
    Rinsho Ketsueki; 2005 Oct; 46(10):1109-13. PubMed ID: 16440772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current options to manage Waldenström's macroglobulinemia.
    Benevolo G; Nicolosi M; Santambrogio E; Vitolo U
    Expert Rev Hematol; 2017 Jul; 10(7):637-647. PubMed ID: 28592170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waldenström's macroglobulinemia.
    Cuttner J
    Cancer Invest; 1991; 9(1):107. PubMed ID: 1901510
    [No Abstract]   [Full Text] [Related]  

  • 19. Resolution of Waldenström's macroglubulinemia related isolated neutropenia by immunochemotherapy.
    van Gelder M; van Marion A; Goossens V; Bommer M; Leblond V
    Am J Hematol; 2011 Apr; 86(4):380-2. PubMed ID: 21442645
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia.
    Dimopoulos MA; Gertz MA; Kastritis E; Garcia-Sanz R; Kimby EK; Leblond V; Fermand JP; Merlini G; Morel P; Morra E; Ocio EM; Owen R; Ghobrial IM; Seymour J; Kyle RA; Treon SP
    J Clin Oncol; 2009 Jan; 27(1):120-6. PubMed ID: 19047284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.